ID27544A - Agonis dan antagonis muskarinat - Google Patents

Agonis dan antagonis muskarinat

Info

Publication number
ID27544A
ID27544A IDW20010377A ID20010377A ID27544A ID 27544 A ID27544 A ID 27544A ID W20010377 A IDW20010377 A ID W20010377A ID 20010377 A ID20010377 A ID 20010377A ID 27544 A ID27544 A ID 27544A
Authority
ID
Indonesia
Prior art keywords
muscarinat
agonists
antagonists
muscarinat agonists
Prior art date
Application number
IDW20010377A
Other languages
English (en)
Inventor
Grewal Gurmit
Toy Palmer Anna
Cai Xiong
Latham George Mark
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of ID27544A publication Critical patent/ID27544A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20010377A 1998-08-18 1999-08-16 Agonis dan antagonis muskarinat ID27544A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18

Publications (1)

Publication Number Publication Date
ID27544A true ID27544A (id) 2001-04-12

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010377A ID27544A (id) 1998-08-18 1999-08-16 Agonis dan antagonis muskarinat

Country Status (30)

Country Link
US (5) US6093724A (id)
EP (1) EP1112272B1 (id)
JP (1) JP2002523416A (id)
KR (1) KR20010072784A (id)
CN (1) CN1312812A (id)
AR (1) AR020199A1 (id)
AT (1) ATE227724T1 (id)
AU (1) AU750566B2 (id)
BG (1) BG105256A (id)
BR (1) BR9913072A (id)
CA (1) CA2340946A1 (id)
CO (1) CO5130018A1 (id)
DE (1) DE69903961T2 (id)
EE (1) EE200100096A (id)
ES (1) ES2191455T3 (id)
HK (1) HK1038918A1 (id)
HU (1) HUP0103203A3 (id)
ID (1) ID27544A (id)
IL (1) IL141050A0 (id)
IS (1) IS5827A (id)
NO (1) NO20010804L (id)
NZ (1) NZ509762A (id)
PE (1) PE20000988A1 (id)
PL (1) PL346247A1 (id)
RU (1) RU2219179C2 (id)
SK (1) SK1892001A3 (id)
TR (1) TR200100462T2 (id)
WO (1) WO2000011001A1 (id)
YU (1) YU13301A (id)
ZA (1) ZA200100978B (id)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292160A1 (en) * 2000-10-19 2002-04-29 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) * 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
CN102690265A (zh) 2007-03-23 2012-09-26 雅培制药有限公司 4-取代的氮杂金刚烷衍生物及其使用方法
ES2378116T3 (es) * 2007-03-23 2012-04-09 Abbott Laboratories Derivados acetamida y carboxamida de azaadamantano y métodos de uso de los mismos
JP2012530084A (ja) * 2009-06-19 2012-11-29 アボット・ラボラトリーズ ジアザホモアダマンタン誘導体およびこの使用方法
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
ES2742728T3 (es) 2009-07-22 2020-02-17 PureTech Health LLC Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
PE20131394A1 (es) 2010-09-23 2014-01-11 Abbvie Inc Monohidrato de derivados de aza-adamantano
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
US11325896B2 (en) 2017-12-20 2022-05-10 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
CA3114623C (en) 2018-09-28 2023-01-10 Karuna Therapeutics, Inc. Composition comprising xanomeline and trospium for treating disorders ameliorated by muscarinic receptor activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
KR100277482B1 (ko) * 1995-11-02 2001-01-15 페더 벨링 신경전달물질 재흡수 저해제인 융합구조의 트로판 유도체
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
AU750566B2 (en) 2002-07-25
AU5775899A (en) 2000-03-14
HUP0103203A3 (en) 2002-10-28
CN1312812A (zh) 2001-09-12
EP1112272A1 (en) 2001-07-04
CO5130018A1 (es) 2002-02-27
NO20010804D0 (no) 2001-02-16
US6323194B1 (en) 2001-11-27
CA2340946A1 (en) 2000-03-02
AR020199A1 (es) 2002-05-02
US6251916B1 (en) 2001-06-26
WO2000011001A1 (en) 2000-03-02
US6555550B1 (en) 2003-04-29
EE200100096A (et) 2002-06-17
HUP0103203A2 (hu) 2002-01-28
JP2002523416A (ja) 2002-07-30
DE69903961T2 (de) 2003-07-03
DE69903961D1 (de) 2002-12-19
ATE227724T1 (de) 2002-11-15
US20020045617A1 (en) 2002-04-18
IS5827A (is) 2001-01-26
BR9913072A (pt) 2001-05-15
HK1038918A1 (zh) 2002-04-04
BG105256A (en) 2001-11-30
ES2191455T3 (es) 2003-09-01
EP1112272B1 (en) 2002-11-13
PL346247A1 (en) 2002-01-28
IL141050A0 (en) 2002-02-10
SK1892001A3 (en) 2001-11-06
PE20000988A1 (es) 2000-09-30
NZ509762A (en) 2002-12-20
YU13301A (sh) 2005-06-10
RU2219179C2 (ru) 2003-12-20
US6093724A (en) 2000-07-25
KR20010072784A (ko) 2001-07-31
US6423842B1 (en) 2002-07-23
NO20010804L (no) 2001-04-11
TR200100462T2 (tr) 2001-09-21
ZA200100978B (en) 2002-02-05

Similar Documents

Publication Publication Date Title
ID26099A (id) Turunan amida dan antagonis nosiseptin
ID27544A (id) Agonis dan antagonis muskarinat
ID28291A (id) Agonis reseptor 5hti dan metoklopramida untuk penyembuhan migren
ID18003A (id) Antagonis muskarinik
DE69934881D1 (de) Selective il-2 agonisten und antagonisten
LV11460A (lv) Estrogenu agonisti un antagonisti
EE9900479A (et) Asendis 5 ja 6 modifitseeritud GnRH antagonistid
ID26639A (id) Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID26248A (id) Turunan asiguanidina baru sebagai inhibitor penyerapan tulang dan sebagai antagonis reseptor vitronektin
ID19623A (id) Antagonis reseptor vitronektin
ID22957A (id) Senyawa dan penggunaannya
ID30401A (id) Turunan-turunan indol dan penggunaannya sebagai antagonis mcp-1
ID17182A (id) Adrenergis b3 agonis pilihan
ID26848A (id) Koupling untuk gigi-gigi eksapator dan sejenisnya
ID24196A (id) Komposisi dan penggunaan
ZA974147B (en) Somatostatin agonists and antagonists.
ID26599A (id) Turunan triazola dan imidazola
ID22916A (id) Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
ID26223A (id) Antagonis reseptor vitronektin
ID23258A (id) Penarik pemberian-menyilang dan metodenya
ID28811A (id) Antagonis reseptor vitronektin
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina